{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:51:55Z","timestamp":1789761115855,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":5084,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1093\/annonc\/mdj025","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T13:47:09Z","timestamp":1129816029000},"page":"135-140","source":"Crossref","is-referenced-by-count":90,"title":["Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma"],"prefix":"10.1016","volume":"17","author":[{"given":"K.","family":"Tanimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdj025_bb0010","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","article-title":"Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma","volume":"52","author":"Isaacson","year":"1983","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdj025_bb0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdj025_bb0020","series-title":"World Health Organization Classification of Tumors. Pathology and Genetics of Haematopoietic and Lymphoid Tissue","first-page":"157","article-title":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson","year":"2001"},{"key":"10.1093\/annonc\/mdj025_bb0025","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","article-title":"Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients","volume":"15","author":"Thieblemont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj025_bb0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","article-title":"Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed","volume":"95","author":"Thieblemont","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdj025_bb0035","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","article-title":"High relapse rate in patients with MALT lymphoma warrants lifelong follow-up","volume":"11","author":"Raderer","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdj025_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MO:22:1:057","article-title":"Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial","volume":"22","author":"Aviles","year":"2005","journal-title":"Med Oncol"},{"key":"10.1093\/annonc\/mdj025_bb0045","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/cncr.11317","article-title":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area","volume":"97","author":"Wenzel","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdj025_bb0050","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj025_bb0055","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0360-3016(01)01549-8","article-title":"Stage I and II MALT lymphoma: results of treatment with radiotherapy","volume":"50","author":"Tsang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdj025_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(98)00535-5","article-title":"Radiotherapy in the management of orbital lymphoma","volume":"44","author":"Bolek","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdj025_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdj025_bb0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0360-3016(01)02729-8","article-title":"Primary radiotherapy for localized orbital MALT lymphoma","volume":"52","author":"Le","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdj025_bb0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0360-3016(02)02966-8","article-title":"Curative radiotherapy for primary orbital lymphoma","volume":"54","author":"Bhatia","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdj025_bb0080","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdj025_bb0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cncr.11539","article-title":"Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa","volume":"98","author":"Uno","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdj025_bb0090","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428199909058411","article-title":"Histology according to the revised European-American lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma","volume":"32","author":"Nakata","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdj025_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajh.10332","article-title":"Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients","volume":"73","author":"Cho","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1093\/annonc\/mdj025_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.84.8.907","article-title":"Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival","volume":"84","author":"Jenkins","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/annonc\/mdj025_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bjo.85.1.63","article-title":"Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification","volume":"85","author":"Auw-Haedrich","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1093\/annonc\/mdj025_bb0110","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin's lymphoma","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdj025_bb0115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","article-title":"Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomized controlled trial","volume":"362","author":"Ardeshna","year":"2003","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdj025_bb0120","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","article-title":"II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy","volume":"22","author":"Advani","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj025_bb0125","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ophtha.2003.09.049","article-title":"Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma","volume":"111","author":"Matsuo","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1093\/annonc\/mdj025_bb0130","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0046-8177(90)90181-4","article-title":"Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit conjunctiva and eyelids) a prospective multiparametric analysis of 108 cases during 1977 to 1987","volume":"21","author":"Knowles","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdj025_bb0135","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Thi\u00e9blemont C et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdj025_bb0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdj025_bb0145","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1200\/JCO.2005.07.083","article-title":"Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy","volume":"23","author":"Ferreri","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj025_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","article-title":"Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy","volume":"357","author":"Liu","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdj025_bb0155","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel","year":"2003","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419403359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/1\/135\/380074\/mdj025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T12:25:02Z","timestamp":1582201502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419403359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0923753419403359"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdj025","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}